News

Talented Heart Research Institute (HRI) bioengineer Dr Steven Wise is taking up an exciting opportunity to further his innovative research program with the HRI’s close collaborative partner The University of Sydney (USYD).

Recently, ten bright young researchers from New Zealand took part in a summer scholarship at the HRI to get hands-on experience in our world-class laboratory facilities and to be mentored by leaders in the cardiovascular disease research field. They share their experiences here.

Congratulations to Manisha Patil, Bob Lee and Dr Richard Tan on receiving awards at the Australian Society for Medical Research (ASMR) Annual Scientific Meeting on Friday 31 May.

Preeclampsia (high blood pressure during pregnancy) is the leading cause of stillbirths and newborn deaths in Australia. It also doubles a woman’s risk of heart disease and stroke later in life.

HRI's Professor Annemarie Hennessy talks to Channel 7 News about preeclampsia.

Scientists at the Heart Research Institute in Sydney have developed a simple, cheap and efficient way to collect nanoparticles that can be used in the treatment of cancer, cardiovascular disease and Alzheimer’s.

In Australia, cardiovascular disease continues to take the lives of 22 females every day – killing almost three times more women than breast cancer. Preeclampsia and gestational diabetes developed during pregnancy can significantly increase a woman’s risk of heart disease later in life, but these can be manageable complications if monitored.

Congratulations to Professor Annemarie Hennessy AM, recently named Distinguished Professor by Western Sydney University.

In March, HRI celebrated 30 years of groundbreaking research and new discoveries that have contributed to an improved understanding of cardiovascular disease.

The Federal Government has reaffirmed its commitment in the Budget to fully fund the Medical Research Future Fund (MRFF).